Abbott LaboratoriesvsMcKesson

ABT and MCK stock compared: price, dividend, valuation and results, from SEC filings.

ABT

Abbott Laboratories

$107.45

Value $187B

-0.99%
ABT's page

MCK

McKesson Corporation

$1,105.04

Value $133B

+0.20%
MCK's page

Abbott Laboratories (ABT) has a market value of $187B and McKesson (MCK) $133B. Over the last year, with dividends, ABT moved -15.7% and MCK +31.7%. The P/E is 39.7 for ABT and 28.3 for MCK. Dividend yield: ABT 2.35%, MCK 0.31%.

At a glance

The main figures of both. A bar only shows which number is larger, not which is better.

  • Market value

    ABT$187B

    MCK$133B

    ABT is 1.4 times MCK

  • Revenue, 12 months

    ABT$48.2B

    MCK$419B

    MCK is 8.7 times ABT

  • Net income, 12 months

    ABT$4.7B

    MCK$4.7B

    About the same

  • Operating margin

    ABT13.8%

    MCK1.6%

    12.2 points apart

  • ROIC

    ABT6.3%

    MCK104.0%

    97.7 points apart

  • P/E

    ABT39.7

    MCK28.3

    ABT is 1.4 times MCK

  • Dividend yield

    ABT2.4%

    MCK0.3%

    2.1 points apart

  • 5-year return

    ABT-8.3%

    MCK+410.9%

    419.2 points apart

A fainter bar means a negative number. The 5-year return includes dividends.

The price over time

Both start at 100 at the beginning of the period, so the lines show how much each changed. With dividends means each dividend buys more shares.

ABT-8.3%

MCK+410.9%

20040020222023202420252026
Returns by period
PeriodABTWith dividendsMCKWith dividends
1 year since November 14, 2025-15.7%Price -17.7%+31.7%Price +31.2%
3 years since November 16, 2023+14.2%+4.5% a yearPrice +7.2%+148.4%+35.4% a yearPrice +145.1%
5 years since November 15, 2021-8.3%-1.7% a yearPrice -17.0%+410.9%+38.6% a yearPrice +397.9%
10 years since November 16, 2016+224.5%+12.5% a yearPrice +169.0%+743.0%+23.8% a yearPrice +681.1%

Each cell: the total return with dividends, its yearly rate, and the price change alone. Before taxes and costs. Past returns do not predict future ones.

Every figure

As on each company's page. A description, not a recommendation: no one figure says which is better.

ABTAbbott LaboratoriesMCKMcKesson

Valuation

ABTMCK
Valuation
Price$107.45$1,105.04
Market value$187B$133B
Enterprise value (EV)$214B$136B
P/E39.728.3
P/E, 5-year median33.724.0
P/B3.7–
EV/EBIT32.120.3
Free cash flow yield3.6%5.4%

Results and growth

ABTMCK
Results and growth
Revenue, 12 months$48.2B$419B
Net income, 12 months$4.7B$4.7B
Free cash flow, 12 months$6.8B$7.1B
Earnings per share, 12 months$2.69$38.83
Revenue growth, year on year5.7%12.4%
Revenue growth a year, past+5.1%over 5 years+11.1%over 5 years
EPS growth a year, past+8.3%over 5 years–

Margins and returns on capital

ABTMCK
Margins and returns on capital
Gross margin56.9%3.7%
Operating margin13.8%1.6%
Net margin9.8%1.1%
ROIC6.3%104.0%
ROE9.1%–

Balance sheet

ABTMCK
Balance sheet
Cash$4.3B$6.5B
Total debt$31.2B$11.2B
Net debt / EBITDA3.30.4
Interest cover6.7×21.9×

Dividends and buybacks

ABTMCK
Dividends and buybacks
Dividend yield2.4%0.3%
Dividend per share, 12 months$2.52$3.40
Dividend growth a year, past+10.4%over 5 years+13.7%over 5 years
Buyback yield0.5%3.6%
Shareholder yield2.8%3.9%

Last 12 months from the latest 10-Q and 10-K. Value, P/E and yields at today's price. A dash means the figure does not exist or did not pass our checks.

Questions: ABT or MCK

Didn't find what you were looking for?

Ask us
Which is bigger, Abbott Laboratories or McKesson?

By market value, Abbott Laboratories ($187B) is about 1.4 times McKesson ($133B), at today's prices.

How did ABT and MCK stock do over the last 10 years?

Since November 16, 2016, ABT's price moved +169.0% and MCK's +681.1%. With dividends: ABT +224.5% (+12.5% a year), MCK +743.0% (+23.8% a year). Past returns do not predict future ones.

Which pays the higher dividend, ABT or MCK?

The dividend yield at today's price is 2.35% for Abbott Laboratories and 0.31% for McKesson. Over the last twelve months they paid $2.52 and $3.40 per share.

What is the P/E of ABT and MCK?

At today's price, the P/E is 39.7 for ABT and 28.3 for MCK. The median of the last five years was 33.7 and 24.0, which shows where each stands against its own past.

Which has the higher profit margins, Abbott Laboratories or McKesson?

Over the last twelve months, the net margin was 9.8% for Abbott Laboratories and 1.1% for McKesson, and the operating margin 13.8% and 1.6%. Revenue was $48.2B and $419B.

Which is the better investment, Abbott Laboratories or McKesson?

The page does not answer that and does not suggest buying or selling. It puts the two companies' numbers side by side, from their SEC filings, for you to read and form your own view. The decision depends on your goals and situation.

Other comparisons

With each of the two, and with the largest in its sector.

Related pages

The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.

Descriptive data from SEC filings and market prices.